Author:
Lim Emilia L,Trinh Diane L,Scott David W,Chu Andy,Krzywinski Martin,Zhao Yongjun,Robertson A Gordon,Mungall Andrew J,Schein Jacqueline,Boyle Merrill,Mottok Anja,Ennishi Daisuke,Johnson Nathalie A,Steidl Christian,Connors Joseph M,Morin Ryan D,Gascoyne Randy D,Marra Marco A
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–11.
2. Shipp MA. A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project N Engl J Med. 1993;329:987–94.
3. Sehn LH, Berry B, Chhanabhai M, Fitzgerald C, Gill K, Hoskins P, et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2007;109:1857–61.
4. Gascoyne RD, Rosenwald A, Poppema S, Lenz G. Prognostic biomarkers in malignant lymphomas. Leuk Lymphoma. 2010;51:11–9.
5. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–66.
Cited by
90 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献